Report Detail
Europe Oncology Biosimilars Market Report 2019
- RnM3847200 |
- 12 December, 2019 |
- Global |
- 109 Pages |
- XYZResearch |
- Medical Devices & Consumables
In this report, our team research the Europe Oncology Biosimilars market by type, application, region and manufacturer 2014-2020 and forcast 2021-2026. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Oncology Biosimilars for these regions, from 2014 to 2026 (forecast), including
Germany
UK
France
Russia
Benelux
Italy
Spain
Europe Oncology Biosimilars market competition by top manufacturers/players, with Oncology Biosimilars sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Celltrion Inc.
Pfizer Inc.
Biocon
BIOCAD
Apotex Inc.
Dr. Reddy's Laboratories Ltd.
Sandoz International GmbH
Intas Pharmaceuticals Ltd.
STADA Arzneimittel AG
Teva Pharmaceutical Industries Ltd.
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
G-CSF
Hematopoietic Agents
Monoclonal Antibodies
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Oncology Biosimilars for each application, including
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Report Overview
- 1.1 Definition and Specification
- 1.2 Report Overview
- 1.2.1 Manufacturers Overview
- 1.2.2 Regions Overview
- 1.2.3 Type Overview
- 1.2.4 Application Overview
- 1.3 Industrial Chain
- 1.3.1 Oncology Biosimilars Overall Industrial Chain
- 1.3.2 Upstream
- 1.3.3 Downstream
- 1.4 Industry Situation
- 1.4.1 Industrial Policy
- 1.4.2 Product Preference
- 1.4.3 Economic/Political Environment
- 1.5 SWOT Analysis
2 Market Analysis by Types
- 2.1 Overall Market Performance(Volume)
- 2.1.1 G-CSF Market Performance (Volume)
- 2.1.2 Hematopoietic Agents Market Performance (Volume)
- 2.1.3 Monoclonal Antibodies Market Performance (Volume)
- 2.2 Overall Market Performance(Value)
- 2.2.1 G-CSF Market Performance (Value)
- 2.2.2 Hematopoietic Agents Market Performance (Value)
- 2.2.3 Monoclonal Antibodies Market Performance (Value)
3 Product Application Market
- 3.1 Overall Market Performance (Volume)
- 3.1.1 Retail Pharmacies Market Performance (Volume)
- 3.1.2 Hospital Pharmacies Market Performance (Volume)
- 3.1.3 Online Pharmacies Market Performance (Volume)
4 Manufacturers Profiles/Analysis
- 4.1 Celltrion Inc.
- 4.1.1 Celltrion Inc. Profiles
- 4.1.2 Celltrion Inc. Product Information
- 4.1.3 Celltrion Inc. Oncology Biosimilars Business Performance
- 4.1.4 Celltrion Inc. Oncology Biosimilars Business Development and Market Status
- 4.2 Pfizer Inc.
- 4.2.1 Pfizer Inc. Profiles
- 4.2.2 Pfizer Inc. Product Information
- 4.2.3 Pfizer Inc. Oncology Biosimilars Business Performance
- 4.2.4 Pfizer Inc. Oncology Biosimilars Business Development and Market Status
- 4.3 Biocon
- 4.3.1 Biocon Profiles
- 4.3.2 Biocon Product Information
- 4.3.3 Biocon Oncology Biosimilars Business Performance
- 4.3.4 Biocon Oncology Biosimilars Business Development and Market Status
- 4.4 BIOCAD
- 4.4.1 BIOCAD Profiles
- 4.4.2 BIOCAD Product Information
- 4.4.3 BIOCAD Oncology Biosimilars Business Performance
- 4.4.4 BIOCAD Oncology Biosimilars Business Development and Market Status
- 4.5 Apotex Inc.
- 4.5.1 Apotex Inc. Profiles
- 4.5.2 Apotex Inc. Product Information
- 4.5.3 Apotex Inc. Oncology Biosimilars Business Performance
- 4.5.4 Apotex Inc. Oncology Biosimilars Business Development and Market Status
- 4.6 Dr. Reddy's Laboratories Ltd.
- 4.6.1 Dr. Reddy's Laboratories Ltd. Profiles
- 4.6.2 Dr. Reddy's Laboratories Ltd. Product Information
- 4.6.3 Dr. Reddy's Laboratories Ltd. Oncology Biosimilars Business Performance
- 4.6.4 Dr. Reddy's Laboratories Ltd. Oncology Biosimilars Business Development and Market Status
- 4.7 Sandoz International GmbH
- 4.7.1 Sandoz International GmbH Profiles
- 4.7.2 Sandoz International GmbH Product Information
- 4.7.3 Sandoz International GmbH Oncology Biosimilars Business Performance
- 4.7.4 Sandoz International GmbH Oncology Biosimilars Business Development and Market Status
- 4.8 Intas Pharmaceuticals Ltd.
- 4.8.1 Intas Pharmaceuticals Ltd. Profiles
- 4.8.2 Intas Pharmaceuticals Ltd. Product Information
- 4.8.3 Intas Pharmaceuticals Ltd. Oncology Biosimilars Business Performance
- 4.8.4 Intas Pharmaceuticals Ltd. Oncology Biosimilars Business Development and Market Status
- 4.9 STADA Arzneimittel AG
- 4.9.1 STADA Arzneimittel AG Profiles
- 4.9.2 STADA Arzneimittel AG Product Information
- 4.9.3 STADA Arzneimittel AG Oncology Biosimilars Business Performance
- 4.9.4 STADA Arzneimittel AG Oncology Biosimilars Business Development and Market Status
- 4.10 Teva Pharmaceutical Industries Ltd.
- 4.10.1 Teva Pharmaceutical Industries Ltd. Profiles
- 4.10.2 Teva Pharmaceutical Industries Ltd. Product Information
- 4.10.3 Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Business Performance
- 4.10.4 Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Business Development and Market Status
5 Market Performance for Manufacturers
- 5.1 Europe Oncology Biosimilars Sales (K Units) and Market Share by Manufacturers 2014-2020
- 5.2 Europe Oncology Biosimilars Revenue (M USD) and Market Share by Manufacturers 2014-2020
- 5.3 Europe Oncology Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
- 5.4 Europe Oncology Biosimilars Gross Margin of Manufacturers 2014-2020
- 5.5 Market Concentration
6 Regions Market Performance for Manufacturers
- 6.1 Germany Market Performance for Manufacturers
- 6.1.1 Germany Oncology Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
- 6.1.2 Germany Oncology Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.1.3 Germany Oncology Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
- 6.1.4 Germany Oncology Biosimilars Gross Margin of Manufacturers 2014-2020
- 6.1.5 Market Concentration
- 6.2 UK Market Performance for Manufacturers
- 6.2.1 UK Oncology Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
- 6.2.2 UK Oncology Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.2.3 UK Oncology Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
- 6.2.4 UK Oncology Biosimilars Gross Margin of Manufacturers 2014-2020
- 6.2.5 Market Concentration
- 6.3 France Market Performance for Manufacturers
- 6.3.1 France Oncology Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
- 6.3.2 France Oncology Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.3.3 France Oncology Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
- 6.3.4 France Oncology Biosimilars Gross Margin of Manufacturers 2014-2020
- 6.3.5 Market Concentration
- 6.4 Russia Market Performance for Manufacturers
- 6.4.1 Russia Oncology Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
- 6.4.2 Russia Oncology Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.4.3 Russia Oncology Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
- 6.4.4 Russia Oncology Biosimilars Gross Margin of Manufacturers 2014-2020
- 6.4.5 Market Concentration
- 6.5 Benelux Market Performance for Manufacturers
- 6.5.1 Benelux Oncology Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
- 6.5.2 Benelux Oncology Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.5.3 Benelux Oncology Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
- 6.5.4 Benelux Oncology Biosimilars Gross Margin of Manufacturers 2014-2020
- 6.5.5 Market Concentration
- 6.6 Italy Market Performance for Manufacturers
- 6.6.1 Italy Oncology Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
- 6.6.2 Italy Oncology Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.6.3 Italy Oncology Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
- 6.6.4 Italy Oncology Biosimilars Gross Margin of Manufacturers 2014-2020
- 6.6.5 Market Concentration
- 6.7 Spain Market Performance for Manufacturers
- 6.7.1 Spain Oncology Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
- 6.7.2 Spain Oncology Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.7.3 Spain Oncology Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
- 6.7.4 Spain Oncology Biosimilars Gross Margin of Manufacturers 2014-2020
- 6.7.5 Market Concentration
- 6.8 Market Performance for Manufacturers
- 6.8.1 Oncology Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
- 6.8.2 Oncology Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.8.3 Oncology Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
- 6.8.4 Oncology Biosimilars Gross Margin of Manufacturers 2014-2020
- 6.8.5 Market Concentration
7 Europe Oncology Biosimilars Market Performance (Sales Point)
- 7.1 Europe Oncology Biosimilars Sales (K Units) and Market Share by Regions 2014-2020
- 7.2 Europe Oncology Biosimilars Revenue (M USD) and Market Share by Regions 2014-2020
- 7.3 Europe Oncology Biosimilars Price (USD/Unit) by Regions 2014-2020
- 7.4 Europe Oncology Biosimilars Gross Margin by Regions 2014-2020
8 Development Trend for Regions (Sales Point)
- 8.1 Europe Oncology Biosimilars Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.2 Germany Oncology Biosimilars Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.3 UK Oncology Biosimilars Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.4 France Oncology Biosimilars Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.5 Russia Oncology Biosimilars Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.6 Benelux Oncology Biosimilars Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.7 Italy Oncology Biosimilars Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.8 Spain Oncology Biosimilars Sales and Growth, Sales Value and Growth Rate2014-2020
9 Upstream Source, Technology and Cost
- 9.1 Upstream Source
- 9.2 Technology
- 9.3 Cost
10 Channel Analysis
- 10.1 Market Channel
- 10.2 Distributors
11 Consumer Analysis
- 11.1 Retail Pharmacies Industry
- 11.2 Hospital Pharmacies Industry
- 11.3 Online Pharmacies Industry
12 Market Forecast 2021-2026
- 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
- 12.1.1 Europe Oncology Biosimilars Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
- 12.1.2 Europe Oncology Biosimilars Sales (K Units) and Growth Rate 2021-2026
- 12.1.3 Germany Oncology Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.4 UK Oncology Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.5 France Oncology Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.6 Russia Oncology Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.7 Benelux Oncology Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.8 Italy Oncology Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.9 Spain Oncology Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
- 12.2.1 Overall Market Performance
- 12.2.2 G-CSF Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.2.3 Hematopoietic Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.2.4 Monoclonal Antibodies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.3 Sales Forecast by Application 2021-2026
- 12.3.1 Overall Market Performance
- 12.3.2 Retail Pharmacies Sales and and Growth Rate 2021-2026
- 12.3.3 Hospital Pharmacies Sales and and Growth Rate 2021-2026
- 12.3.4 Online Pharmacies Sales and and Growth Rate 2021-2026
- 12.4 Price (USD/Unit) and Gross Profit Forecast
- 12.4.1 Europe Oncology Biosimilars Price (USD/Unit) Trend 2021-2026
- 12.4.2 Europe Oncology Biosimilars Gross Profit Trend 2021-2026
13 Conclusion
Summary:
Get latest Market Research Reports on Europe Oncology Biosimilars . Industry analysis & Market Report on Europe Oncology Biosimilars is a syndicated market report, published as Europe Oncology Biosimilars Market Report 2019. It is complete Research Study and Industry Analysis of Europe Oncology Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
